Purchase Order HHSD2002017M92669P
- Not listed
- This is a federal contract award by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, for a service agreement to provide laboratory instruments. The fixed-price purchase order has a ceiling value of $79,756.08 and an ultimate completion date of September 3, 2020. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has previously received awards from various federal agencies including the Department of...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
- This is a $114,707.80 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the provision of laboratory supplies. The contract has no set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and laboratory equipment, has a history of providing critical care analyzers, reagents, test kits, and associated supplies and services to various federal agencies, including the...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
- This is a $84,784.03 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is not set aside and is for the delivery of ROCHE LAB SUPPLIES. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $29,600.00, is for the supply of ROCHE COBAS 5800 REAGENTS under a firm fixed-price purchase order. The contract has an ultimate completion date of June 1, 2024. Roche Diagnostics...
- This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $75,000.00 and was awarded on December 5, 2016 with a completion date of November 12, 2020. The award does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to multiple federal agencies through prime contract awards and GSA Schedule contracts. This award is for a field service agreement, likely to support the provision of laboratory instruments, reagents, and associated services to the CDC's Pittsburgh location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Supplemental Agreement for work within scope | $0 | 5/18/23 | |
| Not listed | Not listed | $18.8k | 12/7/16 |